Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Cardiology

Is Bruising Normal on Dual Antiplatelet Therapy After MI?

At a Glance

Minor bruising and mild bleeding can happen after a heart attack when aspirin is combined with another clot-preventing medicine. Do not stop DAPT on your own; contact your care team about unusual bleeding and call 911 for uncontrolled bleeding, blood in vomit or stool, head injury, or severe symptoms.

Minor bruising and mild bleeding are common—though not universal—when you are on dual antiplatelet therapy (DAPT) after a heart attack [1][2]. Because these medications are specifically meant to keep your blood from clotting too easily, you may bruise and bleed more than usual. While nuisance bleeding is frequent, do not skip or stop DAPT on your own for ordinary bruising. Stopping suddenly, especially soon after a stent placement, dramatically increases your risk of a life-threatening blood clot in your heart [3][4].

Why You Are Bruising

After a heart attack (acute myocardial infarction) or the placement of a coronary stent, your care team likely prescribed DAPT, which involves taking aspirin alongside a P2Y12 inhibitor (such as clopidogrel, ticagrelor, or prasugrel) [5]. Platelets are tiny cell fragments in your blood that stick together to form clots [6]. DAPT inhibits this action, which protects your heart but also means your blood takes longer to clot when small blood vessels are damaged under the skin [1].

Normal Bleeding (Monitor and Mention at Follow-Up)

Most bleeding on DAPT does not require an emergency room visit. Normal, non-emergency bleeding includes:

  • Small, painless bruises from minor bumps
  • Occasional, mild nosebleeds that stop with pressure
  • Gums that bleed slightly when you brush your teeth
  • Small cuts that take a few extra minutes to stop bleeding [2]

First Aid Tip: For a nosebleed, sit forward and pinch the soft part of your nose continuously for 10-15 minutes. For a cut, apply uninterrupted, firm direct pressure [7].

When to Call Your Care Team Today

If you experience bleeding that is not an emergency but is unusual or concerning, call your cardiologist’s office for same-day advice:

  • Frequent or large bruises, especially if they are very painful, hard, or appear without an injury.
  • Hematuria (blood in urine): Urine that is pink, red, or dark brown usually requires prompt medical assessment, though it is not always a 911 emergency unless accompanied by heavy clots, inability to urinate, or faintness [8].
  • Missing a dose: If you miss a dose of your medication, call your pharmacist or doctor. Do not double your next dose.
  • Dental work or surgery: Inform all your doctors and dentists you are on DAPT. Never stop your medication for a procedure without your cardiologist’s approval [9].

When to Call 911 (Emergency Bleeding and Symptoms)

Some types of bleeding are dangerous and require immediate emergency care. If you experience these, call 911. Tell emergency responders exactly what medications you take and when you last took them; they will guide any temporary interruption of your medication [7].

  • Uncontrolled bleeding: Any bleeding that will not stop after 10 to 15 minutes of firm, continuous pressure [7].
  • Gastrointestinal (GI) bleeding: Vomiting blood (which may look like dark coffee grounds), or having bowel movements that are bloody, black, or tarry [10][8].
  • Head Injuries: If you have a fall or blow to the head, seek urgent emergency assessment, even if there is no visible cut. Head injuries can cause delayed brain bleeding [6].
  • Intracranial bleeding (bleeding in the brain): A sudden severe headache, confusion, difficulty speaking, loss of vision, or sudden weakness on one side of your body [6].
  • Catheter-site complications: If you had a catheter placed in your wrist or groin, watch the site. Call for emergency help if you develop rapidly expanding or tense swelling, a pulsating lump, severe/worsening pain, loss of sensation, ongoing bleeding, or if your hand/leg becomes cold, pale, or blue. These can be signs of a hematoma (a pocket of trapped blood) or an arterial occlusion (a blocked artery) [11][12][13].
  • Signs of internal bleeding or recurrent heart attack: Extreme dizziness, fainting, shortness of breath, pale/clammy skin, rapid heartbeat, or new/returning chest pressure [10][14].

How Your Care Team Manages Your Risk

Your doctors actively monitor your bleeding risk and tailor your treatment to keep you safe [5]. They do this by:

  • Reviewing your medical profile: Doctors evaluate your kidney function (creatinine), blood counts (hemoglobin and platelets), age, and prior bleeding history [15][16]. They may use tools like the PRECISE-DAPT score to help inform shared decisions about how long you should stay on DAPT, though these scores do not replace clinical judgment [17][18]. Normal lab results do not completely rule out acute bleeding, but they help assess your overall baseline risk.
  • Managing drug interactions: Over-the-counter painkillers like NSAIDs (ibuprofen, naproxen) and prescription blood thinners (anticoagulants) amplify your bleeding risk [19][20]. Always clear new medications or supplements with your pharmacist.
  • Considering stomach protectors: To reduce the risk of GI bleeding, doctors often prescribe a proton pump inhibitor (PPI) (a medication that reduces stomach acid) [21][22]. However, do not start an over-the-counter PPI on your own. Some PPIs (like omeprazole) can interfere with how clopidogrel works, so your clinician must select the safest option for you [23][10].

Common questions in this guide

Is some bruising expected after a heart attack when I take DAPT?
Small, painless bruises and mild bleeding can occur with dual antiplatelet therapy because aspirin and the second medicine make platelets less likely to form clots. Frequent, large, painful, hard, or unexplained bruises should be reported to your care team.
Should I stop my antiplatelet medicines if I notice a bruise?
Do not stop or skip DAPT on your own for an ordinary bruise. Stopping suddenly, especially soon after a coronary stent, can raise the risk of a dangerous clot; contact your cardiologist before making any change.
When does bleeding on DAPT require a 911 call?
Call 911 for bleeding that does not stop after 10 to 15 minutes of firm, continuous pressure, vomiting blood, or bloody, black, or tarry stools. Get emergency help after a head injury or for sudden severe headache, confusion, trouble speaking, one-sided weakness, fainting, severe shortness of breath, or new chest pressure.
What should I do if I see blood in my urine while taking DAPT?
Pink, red, or dark-brown urine should prompt a same-day call to your care team for medical advice. Seek emergency help if there are heavy clots, you cannot urinate, or you feel faint.
Can ibuprofen or naproxen increase bleeding risk with DAPT?
Yes. NSAID pain relievers such as ibuprofen and naproxen can increase bleeding risk when combined with antiplatelet medicines, and prescription blood thinners can add risk too. Ask a pharmacist or doctor before starting any pain reliever, supplement, or new medicine.
Do I need to tell my dentist or surgeon that I take DAPT?
Yes. Tell every doctor and dentist that you take dual antiplatelet therapy before a procedure. Do not stop either medicine for dental work or surgery unless the cardiologist managing your heart treatment specifically approves it.
Could I need a stomach-protecting medicine while taking DAPT?
Some people at increased risk of gastrointestinal bleeding may be prescribed a proton pump inhibitor, or PPI. Do not start an over-the-counter PPI without medical advice because some options, including omeprazole, can interfere with clopidogrel.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Related questions

Heart Attack Fatigue: How Long and When Is Activity Safe? How Long Can Troponin Stay High After a Heart Attack? Missed Antiplatelet Dose After a Heart Attack or Stent? What Happens After a MINOCA Heart Attack Diagnosis? How Do I Care for My Catheter Site After an Angiogram?
Show more
Should I Chew Aspirin for a Suspected Heart Attack? Are Palpitations After a Heart Attack Dangerous? Monitoring When Is an ICD Considered After a Heart Attack with Low EF? What Are Heart Failure Warning Signs After a Heart Attack? What Does LVEF Mean After a Heart Attack? Explained How Are Mental Health Symptoms Treated After a Heart Attack? How Do I Prevent Stent Thrombosis and Restenosis After MI? Does Type 2 MI Need a Stent or the Same Medications? How Are Myocarditis and Takotsubo Unlike a Heart Attack? What Is SCAD and How Is a SCAD Heart Attack Treated? Why Are Heparin and Antiplatelets Both Used in PCI? Why Was I Given a Stent or Clot-Buster for My Heart Attack? What Happens During a Coronary Angiogram and Stent? What Mechanical Complications Follow a Heart Attack?

Get notified when new evidence is published on acute myocardial infarction.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is my current level of bruising expected for the specific antiplatelet medications I am taking?
  2. 2.Do I have any specific risk factors, like my kidney function or age, that make me more likely to experience bleeding?
  3. 3.Should I be taking a stomach protector (like a PPI) to prevent gastrointestinal bleeding, and does it safely interact with my antiplatelet drug?
  4. 4.What is our target timeline for my dual antiplatelet therapy, and what factors will help inform when it is safe to adjust my dose?
  5. 5.Are any of my other daily medications, supplements, or over-the-counter pain relievers increasing my bleeding risk?

References

References (23)
  1. 1

    Impact of antiplatelet therapy on erectile dysfunction following percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.

    Choi J, Lee CU, Park HW, et al.

    Frontiers in medicine 2026; (13()):1874442 doi:10.3389/fmed.2026.1874442.

    PMID: 42755832
  2. 2

    Assessing the Utility of the DAPT Score and PRECISE-DAPT Score in Determining the Appropriateness of Dual Antiplatelet Therapy in Patients With Acute Myocardial Infarction/Percutaneous Coronary Intervention.

    Singh A, Hussain MA, Chaudhary SC, et al.

    Cardiology research and practice 2024; (2024()):1489008 doi:10.1155/2024/1489008.

    PMID: 39512265
  3. 3

    Stent thrombosis: an updated clinical overview from epidemiology to classification and management.

    Granata LG, Marchetta M, Alagna G, et al.

    Heart (British Cardiac Society) 2026; doi:10.1136/heartjnl-2026-327899.

    PMID: 42103453
  4. 4

    Dual Antiplatelet Therapy Discontinuation, Platelet Reactivity, and Adverse Outcomes After Successful Percutaneous Coronary Intervention.

    Redfors B, Kirtane AJ, Liu M, et al.

    JACC. Cardiovascular interventions 2022; (15(8)):797-806 doi:10.1016/j.jcin.2022.01.300.

    PMID: 35450679
  5. 5

    Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks.

    Gorog DA, Ten Berg JM, Campo G, et al.

    European heart journal. Acute cardiovascular care 2026; (15(4)):337-363 doi:10.1093/ehjacc/zuag021.

    PMID: 41914626
  6. 6

    Oral Antiplatelet Therapy After Acute Coronary Syndrome: A Review.

    Kamran H, Jneid H, Kayani WT, et al.

    JAMA 2021; (325(15)):1545-1555 doi:10.1001/jama.2021.0716.

    PMID: 33877270
  7. 7

    [Severe bleeding with antiplatelet therapy: What to do?]

    Cayla G, Cornillet L, Ledermann B, et al.

    Presse medicale (Paris, France : 1983) 2019; (48(12)):1416-1421 doi:10.1016/j.lpm.2019.08.017.

    PMID: 31679898
  8. 8

    Effects of proton pump inhibitors on gastrointestinal bleeding and cardiovascular outcomes in myocardial infarction patients treated with DAPT.

    Kang D, Choi KH, Park H, et al.

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2025; (21(4)):e229-e239 doi:10.4244/EIJ-D-24-00673.

    PMID: 39962947
  9. 9

    Summary of the European Society of Cardiology guidelines on dual antiplatelet therapy in patients after percutaneous coronary interventions.

    Hudzik B, Błachut A, Lesiak M, et al.

    Kardiologia polska 2022; (80(10)):974-989 doi:10.33963/KP.a2022.0198.

    PMID: 36036339
  10. 10

    Treatment and prevention of gastrointestinal bleeding in patients receiving antiplatelet therapy.

    Yasuda H, Matsuo Y, Sato Y, et al.

    World journal of critical care medicine 2015; (4(1)):40-6 doi:10.5492/wjccm.v4.i1.40.

    PMID: 25685721
  11. 11

    Radial Artery Pseudoaneurysm Following Transradial Catheterization: Recognition, Management, and Prevention.

    Carvajal MC, Shirodkar S, Briscoe JB, et al.

    Journal of the Society for Cardiovascular Angiography & Interventions 2026; (5(7)):105401 doi:10.1016/j.jscai.2026.105401.

    PMID: 42502332
  12. 12

    Transradial Artery Access Complications.

    Sandoval Y, Bell MR, Gulati R

    Circulation. Cardiovascular interventions 2019; (12(11)):e007386 doi:10.1161/CIRCINTERVENTIONS.119.007386.

    PMID: 31672030
  13. 13

    Radial Artery Access Complications: Prevention, Diagnosis and Management.

    Roy S, Kabach M, Patel DB, et al.

    Cardiovascular revascularization medicine : including molecular interventions 2022; (40()):163-171 doi:10.1016/j.carrev.2021.12.007.

    PMID: 34952824
  14. 14

    Differential Prognostic Impact on Mortality of Myocardial Infarction Compared With Bleeding Severity in Contemporary Acute Coronary Syndrome Patients.

    Caneiro-Queija B, Abu-Assi E, Raposeiras-Roubín S, et al.

    Revista espanola de cardiologia (English ed.) 2018; (71(10)):829-836 doi:10.1016/j.rec.2018.02.008.

    PMID: 29656987
  15. 15

    Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS.

    Baber U, Mehran R, Giustino G, et al.

    Journal of the American College of Cardiology 2016; (67(19)):2224-2234 doi:10.1016/j.jacc.2016.02.064.

    PMID: 27079334
  16. 16

    Antiplatelet Therapy in Low-Platelet-Count Patients After Percutaneous Coronary Intervention for Acute Coronary Syndromes.

    Paciullo F, Gresele P

    Journal of clinical medicine 2025; (14(3)) doi:10.3390/jcm14030838.

    PMID: 39941509
  17. 17

    Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.

    Costa F, van Klaveren D, James S, et al.

    Lancet (London, England) 2017; (389(10073)):1025-1034 doi:10.1016/S0140-6736(17)30397-5.

    PMID: 28290994
  18. 18

    Validation of the 4-Item PRECISE-DAPT Score: A SWEDEHEART Study.

    Wester A, Mohammad MA, Olivecrona G, et al.

    Journal of the American Heart Association 2021; (10(20)):e020974 doi:10.1161/JAHA.121.020974.

    PMID: 34612051
  19. 19

    Bleeding in Antiplatelet Therapy: A Narrative Review of Clinical Evidence and the Roles of Pharmacists and Nurses.

    Xu F, Zhang ZH, Li LC, et al.

    Reviews in cardiovascular medicine 2025; (26(11)):45077 doi:10.31083/RCM45077.

    PMID: 41356311
  20. 20

    Gastroprotection in patients on antiplatelet and/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO).

    Abrignani MG, Gatta L, Gabrielli D, et al.

    European journal of internal medicine 2021; (85()):1-13 doi:10.1016/j.ejim.2020.11.014.

    PMID: 33279389
  21. 21

    Meta-Analysis of Efficacy and Safety of Proton Pump Inhibitors with Dual Antiplatelet Therapy for Coronary Artery Disease.

    Khan SU, Lone AN, Asad ZUA, et al.

    Cardiovascular revascularization medicine : including molecular interventions 2019; (20(12)):1125-1133 doi:10.1016/j.carrev.2019.02.002.

    PMID: 30773427
  22. 22

    Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.

    Vaduganathan M, Bhatt DL, Cryer BL, et al.

    Journal of the American College of Cardiology 2016; (67(14)):1661-71.

    PMID: 27012778
  23. 23

    Clinical pharmacology of antiplatelet drugs.

    Gelbenegger G, Jilma B

    Expert review of clinical pharmacology 2022; (15(10)):1177-1197 doi:10.1080/17512433.2022.2121702.

    PMID: 36065676

This page is for informational purposes only and does not constitute medical advice. It explains bruising and bleeding on DAPT after a heart attack; do not stop antiplatelet medicine without your cardiologist's advice, and seek emergency care for severe bleeding.